S K Sohn

Author PubWeight™ 36.26‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Robotic tumor-specific mesorectal excision of rectal cancer: short-term outcome of a pilot randomized trial. Surg Endosc 2008 1.46
2 Impact of ABO incompatibility on outcome after allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant 2005 1.42
3 Rupture of the rectosigmoid colon with evisceration of the small bowel through the anus. Yonsei Med J 2000 1.29
4 Comparative study of transrectal ultrasonography, pelvic computerized tomography, and magnetic resonance imaging in preoperative staging of rectal cancer. Dis Colon Rectum 1999 1.23
5 New myeloablative conditioning regimen with fludarabine and busulfan for allogeneic stem cell transplantation: comparison with BuCy2. Bone Marrow Transplant 2007 1.21
6 Telomere length changes in patients with aplastic anaemia. Br J Haematol 2001 1.15
7 Protective role of interleukin-10 promoter gene polymorphism in the pathogenesis of invasive pulmonary aspergillosis after allogeneic stem cell transplantation. Bone Marrow Transplant 2005 1.14
8 Absolute lymphocyte counts predicts response to chemotherapy and survival in diffuse large B-cell lymphoma. Leukemia 2007 1.14
9 Rapid helper T-cell recovery above 200 x 10 6/l at 3 months correlates to successful transplant outcomes after allogeneic stem cell transplantation. Bone Marrow Transplant 2006 1.11
10 Clinical heterogeneity of extranodal NK/T-cell lymphoma, nasal type: a national survey of the Korean Cancer Study Group. Ann Oncol 2008 1.08
11 Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with gastric cancer. Ann Oncol 2007 1.07
12 Wernicke's encephalopathy after allogeneic stem cell transplantation. Bone Marrow Transplant 2005 1.03
13 Phase II study of concurrent chemoradiotherapy with capecitabine and cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck. Br J Cancer 2005 0.96
14 Multicenter study of intravenous busulfan, cyclophosphamide, and etoposide (i.v. Bu/Cy/E) as conditioning regimen for autologous stem cell transplantation in patients with non-Hodgkin's lymphoma. Bone Marrow Transplant 2007 0.90
15 Pilot study on the use of zoledronic acid to prevent bone loss in allo-SCT recipients. Bone Marrow Transplant 2009 0.90
16 Time to first flare-up episode of GVHD can stratify patients according to their prognosis during clinical course of progressive- or quiescent-type chronic GVHD. Bone Marrow Transplant 2007 0.89
17 Intramedullary fat necrosis of multiple bones associated with pancreatitis. J Nucl Med 1998 0.88
18 A case of bleeding from the Dieulafoy lesion of the jejunum. Yonsei Med J 1997 0.88
19 Volvulus of the splenic flexure of the colon. Yonsei Med J 1994 0.87
20 Clinical impact of hyperacute graft-versus-host disease on results of allogeneic stem cell transplantation. Bone Marrow Transplant 2004 0.86
21 Multicenter phase II study of docetaxel plus oxaliplatin combination chemotherapy in patients with advanced gastric cancer: Daegu Gyeongbuk Oncology Group. Br J Cancer 2008 0.86
22 Influence of enzyme and transporter polymorphisms on trough imatinib concentration and clinical response in chronic myeloid leukemia patients. Ann Oncol 2012 0.85
23 Transrectal ultrasonography in preoperative staging of rectal cancer. Yonsei Med J 1994 0.84
24 Assessment of biomarkers in paired primary and recurrent colorectal adenocarcinomas. Int J Radiat Oncol Biol Phys 1999 0.84
25 Improved therapeutic outcomes of DLBCL after introduction of rituximab in Korean patients. Ann Hematol 2006 0.84
26 Response to high-dose intravenous immune globulin as a valuable factor predicting the effect of splenectomy in chronic idiopathic thrombocytopenic purpura patients. Am J Hematol 2001 0.83
27 Sarcomatous transformation of neurofibromas. Comparative imaging with Ga-67, Tl-201, Tc-99m pentavalent DMSA and Tc-99m MIBI. Clin Nucl Med 1997 0.83
28 Lower gastrointestinal bleeding due to cytomegalovirus ileal ulcers in an immunocompetent man. Yonsei Med J 2001 0.82
29 Risk factors for late cytomegalovirus infection after allogeneic stem cell transplantation using HLA-matched sibling donor: donor lymphocyte infusion and previous history of early CMV infection. Bone Marrow Transplant 2004 0.82
30 Phase II study of capecitabine and irinotecan combination chemotherapy in patients with advanced gastric cancer. Br J Cancer 2006 0.80
31 Ultralow anterior resection and coloanal anastomosis for distal rectal cancer: functional and oncological results. Int J Colorectal Dis 2001 0.80
32 Comparisons of prognostic scoring systems for myelodysplastic syndromes: a Korean multicenter study. Leuk Res 1999 0.80
33 Prognostic significance of platelet recovery pattern after allogeneic HLA-identical sibling transplantation and its association with severe acute GVHD. Bone Marrow Transplant 2006 0.79
34 Effectiveness of transdermal fentanyl patch for treatment of acute pain due to oral mucositis in patients receiving stem cell transplantation. Transplant Proc 2005 0.79
35 Hickman catheter site infections after allogeneic stem cell transplantation: a single-center experience. Transplant Proc 2004 0.78
36 Results of subhepatic fluid collection after cholecystectomy; a serial sonographic study. Yonsei Med J 1987 0.78
37 IVS10+12A>G polymorphism in hMSH2 gene associated with prognosis for patients with colorectal cancer. Ann Oncol 2009 0.77
38 Early onset of acute GVHD indicates worse outcome in terms of severity of chronic GVHD compared with late onset. Bone Marrow Transplant 2010 0.77
39 Multi-drug resistance (MDR1) gene expression in de novo acute leukemia cells: correlations with CD surface markers and treatment outcome. J Korean Med Sci 1998 0.77
40 Hickman catheter site infections after allogeneic stem cell transplantation: single-center experience. Transplant Proc 2004 0.75
41 Gall stones in young adults. Yonsei Med J 1984 0.75
42 Effects of YJA20379-4 on gastric secretion, Helicobacter pylori growth and various gastric and duodenal lesions in rats. Biol Pharm Bull 1998 0.75
43 Inhibitory action of YJA20379, a new proton pump inhibitor on Helicobacter pylori growth and urease. Arch Pharm Res 1998 0.75
44 Determination of a new antiulcer agent, YJA-20379-2, in human plasma and urine by high-performance liquid chromatography. Res Commun Mol Pathol Pharmacol 1996 0.75
45 Biochemical and pharmacological characteristics of 3-butyryl-8-methoxy-4-[(2-thiophenyl)amino]quinoline, a new proton-pump inhibitor, in rabbit gastric microsomes and in rats. J Pharm Pharmacol 1998 0.75
46 A pilot study of cytoreductive chemotherapy combined with infusion of additional peripheral blood stem cells reserved at time of harvest for transplantation in case of relapsed hematologic malignancies after allogeneic peripheral blood stem cell transplant. Bone Marrow Transplant 2004 0.75
47 Use of human amniotic membrane wrap in reducing perineural adhesions in a rabbit model of ulnar nerve neurorrhaphy. J Hand Surg Eur Vol 2009 0.75
48 General pharmacological properties of YJA 20379-1, a novel proton pump inhibitor with antiulcer activities. Arzneimittelforschung 1999 0.75
49 The biochemical and pharmacological properties of a newly synthesized H+-K+ ATPase inhibitor, 2-dimethylamino-4,5-dihydrothiazolo[4,5:3,4]pyridol-[1,2-a]benzimidazol e. Can J Physiol Pharmacol 1998 0.75
50 Restorative proctocolectomy: operative safety and functional outcomes. Yonsei Med J 2000 0.75